SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-046695
Filing Date
2022-04-18
Accepted
2022-04-18 08:08:07
Documents
12
Period of Report
2022-04-15
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2212857d1_8k.htm   iXBRL 8-K 27970
  Complete submission text file 0001104659-22-046695.txt   199225

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ocgn-20220415.xsd EX-101.SCH 3042
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocgn-20220415_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocgn-20220415_pre.xml EX-101.PRE 22601
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2212857d1_8k_htm.xml XML 3481
Mailing Address 263 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 263 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36751 | Film No.: 22831049
SIC: 2836 Biological Products, (No Diagnostic Substances)